Development and enhancements of the icure management system (IMS) provided by MDB INC:1108559 [20-049477]
Ended Awarded
- Contract number
- 75N91020F00003
- Awardee
-
Mdb, Inc. UEI J4KLUDGBKYJ7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $116,610
Award facts
- Contract value 100% obligated
- $116,610.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Washington, DC 20036, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute (NCI) awarded a $116,610 firm fixed-price contract to MDB Inc. (doing business as Michael D. Baker Inc.) on August 27, 2020, for the development and enhancements of the iCure Management System (IMS). This contract was issued as a call under a Blanket Purchase Agreement (BPA) from the General Services Administration's Multiple Award Schedule (MAS) program and was completed by August 31, 2021. The work was performed in Washington, DC, where MDB Inc. maintains its headquarters. No set-aside designation was applied to this award.
MDB Inc., a small business federal contractor registered in the System for Award Management since 2003, specializes in providing professional services to federal agencies across research support, technical communications, and administrative consulting domains. The company has an established track record with the National Institutes of Health and its component institutes, including the NCI, and holds multiple significant Blanket Purchase Agreements and Indefinite Delivery vehicles totaling tens of millions of dollars. The iCure Management System enhancement project aligns with NCI's mission-critical research support infrastructure, leveraging MDB Inc.'s demonstrated capabilities in technical and research support services.
Quick answers
Who was awarded contract 75N91020F00003?
75N91020F00003 was awarded to Mdb, Inc. by National Cancer Institute (National Institutes of Health) on August 27, 2020.
How much is contract 75N91020F00003 worth?
The government has obligated $116,610 on 75N91020F00003.
Is contract 75N91020F00003 an order under another contract?
Yes. 75N91020F00003 is a BPA call under GS00F0001S-HHSN263201000141B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75N91020F00003 competed?
The extent of competition for 75N91020F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award